Seer Investor Relations Material
Latest events
Q1 2025
Seer
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Seer Inc
Access all reports
Seer Inc develops life sciences technologies intended to enable discovery of proteomic biomarkers with high throughput and precision. The company’s products support research in areas such as biomarker identification, disease detection, and therapeutic development. Seer serves pharmaceutical, academic, and research institutions in the life sciences sector. The company is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.
Key slides for Seer Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Seer Inc
43rd Annual J.P. Morgan Healthcare Conference 2025
Seer Inc
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
SEER
Country
🇺🇸 United States